Back

Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery

20 April 2018 (10:00 - 11:00)
Organised by:
Congress Presentation Part of: Moderated Poster Session III Secondary Prevention EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Doctor Lorenzo Brambilla

Don Carlo Gnocchi Onlus Foundation, Parma (Italy)

8 More presentations in this session

Presentation thumbnail
Estimation risk for developing recurrent stroke in young adults with ischemic stokes using the Essen Stroke Risk Score: do women and men had differences risk?
Miss J. Suwanno (Hat Yai, Songkhla, TH)
Presentation thumbnail
A quality improvement project to facilitate annual cardiovascular disease risk assessment in Rheumatoid Arthritis patients: A Mid-Western experience
Doctor M. Khan (Limerick, IE)
Presentation thumbnail
Indications for lowering LDL Cholesterol in Rheumatoid Arthritis: An unrecognized problem
Doctor M. Khan (Limerick, IE)
Presentation thumbnail
Trends in mortality for selected cardiovascular diseases in Croatia between 2001-2016
Doctor V. Kralj (Zagreb, HR)
Abstract Slides
Presentation thumbnail
Risk factors and preventive management of men and women with peripheral artery disease
Assistant Professor B. Jug (Ljubljana, SI)
Abstract

Access the full session

Session thumbnail
Moderated Poster Session III

The Event

Event poster

EuroPrevent 2018

20 April 2018 10:00 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources